EP3349796
MEÐFERÐARSAMSETNINGAR SEM INNIHALDA ÓNÆMISTENGINGAR ANDFOLR1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.9.2016EP published:
8.4.2026EP application number:
16847437.7
EP translation filed:
29.5.2026Grant published:
10.6.2026EPO information:
European Patent Register
Max expiry date:
15.9.2036Expiry date:
15.9.2026
Title in English:
THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATESLanguage of the patent:
English
Timeline
Today
16.9.2016EP application
8.4.2026EP Publication
29.5.2026Translation submitted
10.6.2026Registration published
15.9.2026Expires
Owner
Name:
ImmunoGen, Inc.Address:
1 N. Waukegan Road,, North Chicago, IL 60064, US
Inventor
Name:
PONTE, JoseAddress:
Weymouth, Massachusetts 02188, US
Name:
PINKAS, JanAddress:
Belmont, Massachusetts 02478, US
Name:
RUIZ-SOTO, Rodrigo R.Address:
Boston, Massachusetts 02118, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201562220028 PDate:
17.9.2015Country:
US
Number:
201562242669 PDate:
16.10.2015Country:
US
Number:
201562250756 PDate:
4.11.2015Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, C07K 16/30, C07K 16/46, A61K 45/06, A61K 31/555, A61K 31/704, A61K 33/24, C07K 16/22, A61K 39/00, A61K 47/68, A61P 35/00, A61K 33/243